IDT Biologika

IDT Biologika is a global biopharmaceutical contract development and manufacturing organization that specializes in the production of innovative live viral vaccines, viral vectors for gene and immune therapeutics, oncolytic viruses, virus-like particles, as well as the fill and finish of other sterile liquid and lyophilized biologics to improve human health worldwide.

IDT-Biologika-1.jpeg
IDT-Biologika-1.jpeg

Description

IDT BIOLOGIKA -  WITH PASSION WE BRING PHARMACEUTICAL SOLUTIONS TO LIFE.

IDT Biologika is a global biopharmaceutical contract development and manufacturing organization (CDMO) specializing in vaccines, gene and immune therapeutics, and the fill-finish of other sterile injectables. With decades of experience across various vaccine platforms, we integrate cutting-edge innovations in advanced therapies and our expertise in fill-finish to provide tailored solutions that support our customers in advancing their products.

Our end-to-end services include process development, drug substance manufacturing, sterile dosage filling, labeling, packaging and quality control. All analytical services are performed in-house. From early-stage development to clinical and commercial manufacturing, we ensure seamless integration at every step,
delivering flexibility, regulatory compliance, and the highest quality standards. Our commitment to operational excellence is reflected in our best-in-class process and GMP manufacturing, meeting FDA, EMA and ANVISA standards.

Driven by passion, innovation, and a commitment to excellence, we strive to make a meaningful impact on global healthcare by helping our customers bring their products to market.
www.idt-biologika.com

Key Products and Services:

  • Vaccines: Development and manufacturing of live viral vaccines, leveraging over 100 years of expertise and BSL-2 compliant facilities.
  • Cell & Gene Therapeutics: Support for the development and manufacturing of viral vectors for cell and gene therapies, including commercial manufacturing of oncolytic virus products.
  • Biologics & Sterile Injectables: End-to-end services for live viral products and aseptic liquid filling and lyophilisation of vaccines, recombinant proteins, and antibodies.
  • Development Services: Process development, analytical development, and cell line development to support clients' projects from concept to commercialisation.
  • Biomanufacturing Services: Drug substance manufacturing, aseptic fill-finish, lyophilisation, secondary packaging, quality control, analytics, and regulatory support.

 

Certification
Canada Health Canada, United States FDA, Europe EMA, Germany PEI, GMP

Capabilities

Contact Information

Address
Am Pharmapark
Zip/Post Code
06861

The PharmaSource Newsletter

Register today to our free email newsletter for the latest insights into BioPharma outsourcing.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.